DE602006010542D1 - Verfahren zur herstellung eines nikotinzuführenden produkts - Google Patents

Verfahren zur herstellung eines nikotinzuführenden produkts

Info

Publication number
DE602006010542D1
DE602006010542D1 DE602006010542T DE602006010542T DE602006010542D1 DE 602006010542 D1 DE602006010542 D1 DE 602006010542D1 DE 602006010542 T DE602006010542 T DE 602006010542T DE 602006010542 T DE602006010542 T DE 602006010542T DE 602006010542 D1 DE602006010542 D1 DE 602006010542D1
Authority
DE
Germany
Prior art keywords
nicotine
product
mixture
nicotized
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006010542T
Other languages
English (en)
Inventor
Carsten Andersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fertin Pharma AS
Original Assignee
Fertin Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fertin Pharma AS filed Critical Fertin Pharma AS
Publication of DE602006010542D1 publication Critical patent/DE602006010542D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058Chewing gums
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DE602006010542T 2005-06-01 2006-06-01 Verfahren zur herstellung eines nikotinzuführenden produkts Active DE602006010542D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200500796 2005-06-01
PCT/DK2006/000307 WO2006128468A1 (en) 2005-06-01 2006-06-01 A method of manufacturing a nicotine delivery product

Publications (1)

Publication Number Publication Date
DE602006010542D1 true DE602006010542D1 (de) 2009-12-31

Family

ID=36778046

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006010542T Active DE602006010542D1 (de) 2005-06-01 2006-06-01 Verfahren zur herstellung eines nikotinzuführenden produkts

Country Status (6)

Country Link
US (1) US8986668B2 (de)
EP (1) EP1890698B1 (de)
AT (1) ATE448786T1 (de)
DE (1) DE602006010542D1 (de)
DK (1) DK1890698T3 (de)
WO (1) WO2006128468A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
EP2575760A1 (de) 2010-05-31 2013-04-10 Fertin Pharma A/S Formulierung mit nikotin und einem kationenaustauschharz
US8728444B2 (en) 2010-05-31 2014-05-20 Fertin Pharma A/S Formulation comprising nicotine and a cation exchange resin
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US20140255452A1 (en) 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
US10130120B2 (en) 2013-03-15 2018-11-20 Altria Client Services Llc Use of pectin or other anionic polymers in the stabilization and controlled release of nicotine in oral sensorial tobacco products or nicotine containing non-tobacco oral sensorial products
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
US11311623B2 (en) 2016-04-21 2022-04-26 Fertin Pharma A/S Nicotine delivery product, related uses and oral dosage forms, and methods of production
US11406630B2 (en) * 2017-06-23 2022-08-09 Ncp Nextgen A/S Nicotine pouch
CN112384504A (zh) 2018-06-15 2021-02-19 R.J.雷诺兹烟草公司 烟碱的纯化

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901248A (en) * 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
US3845217A (en) * 1972-11-16 1974-10-29 Helsingborg L Ab Buffered smoking substitute compositions
US6607752B2 (en) * 2000-07-27 2003-08-19 Rohm And Haas Company Method for the anhydrous loading of nicotine onto ion exchange resins
CN1615156B (zh) 2002-01-18 2012-05-30 罗门哈斯公司 制备树脂酸酯的方法
US6586449B1 (en) 2002-05-28 2003-07-01 Cambrex Charles City, Inc. Nicotine-containing, controlled release composition and method
ATE439839T1 (de) * 2003-12-02 2009-09-15 Fertin Pharma As Nikotin-abgabeprodukt und herstellungsverfahren

Also Published As

Publication number Publication date
EP1890698B1 (de) 2009-11-18
US20090092573A1 (en) 2009-04-09
WO2006128468A1 (en) 2006-12-07
US8986668B2 (en) 2015-03-24
DK1890698T3 (da) 2010-03-29
EP1890698A1 (de) 2008-02-27
ATE448786T1 (de) 2009-12-15

Similar Documents

Publication Publication Date Title
DE602006010542D1 (de) Verfahren zur herstellung eines nikotinzuführenden produkts
ATE458535T1 (de) Verfahren zur herstellung von konzentrierten tensidzusammensetzungen
ATE444950T1 (de) Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid
ATE511419T1 (de) Formstoffmischung, formling für giessereizwecke und verfahren zur herstellung eines formlings
CY1108411T1 (el) Συνθεση περιεχουσα νικοτινη ελεγχομενης απελευθερωσης και μεθοδος
ATE489365T1 (de) Verfahren und zwischenprodukte zur herstellung von (1r,2s,5s)-6,6-dimethyl-3-azabicycloä3,1,0 ühexan-2-carboxylaten oder salzen davon
ATE502138T1 (de) Synthetische perlmutter, verfahren und vorrichtung zu ihrer herstellung
DE602006019856D1 (de) Verfahren zur herstellung eines papiers und ein danach hergestelltes papier
DE10344595A1 (de) Verfahren zur Herstellung eines Ketons
ATE439839T1 (de) Nikotin-abgabeprodukt und herstellungsverfahren
ATE340164T1 (de) Verfahren zur herstellung von ionischen flüssigkeiten mit alkylsulfat und funktionalisierten alkylsulfat-anionen
DE602004010775D1 (de) Verfahren zur Herstellung eines Baustoffes
DE602006021606D1 (de) Verfahren zur herstellung eines gaba-haltigen fermentationsprodukts
DE602007003198D1 (de) Verfahren zur herstellung einer zusammensetzung auf 4-hydroxyprolin-basis sowie verwendungen davon auf landwirtschaftlichem gebiet
DE602005011888D1 (de) Verfahren zur Herstellung eines einbügelbaren Einlagestoffs, sowie dadurch hergestellter Einlagestoff
ATE516905T1 (de) Verfahren zum herstellen einer sandform
ATE532767T1 (de) Verfahren zur herstellung eines nn-alkyl-lactams mit verbesserter farbqualität
DE602006012622D1 (de) Verfahren zur herstellung von 1,1,1-tris(4-hydroxyphenyl)alkanen
ATE466010T1 (de) Verfahren zur herstellung von candesartan
DE602005013007D1 (de) Verfahren zur herstellung von lactonen
ATE489390T1 (de) Verfahren zur herstellung eines gemischten olanzapinsolvats
WO2007116011A3 (de) Substituierte triazolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel
ATE394185T1 (de) Verfahren zur herstellung von giesskernnen oder formen
ATE490259T1 (de) Verfahren zur herstellung von alkylphosphinaten
ATE514664T1 (de) Verfahren zur herstellung eines phosphorhaltigen düngemittels aus tiermehl

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: HOFFMANN & EITLE, 81925 MUENCHEN

8364 No opposition during term of opposition